IMPACT and REMODEL projects are excited to invite you to participate in a webinar that aims to explore the omics techniques and how these are used in biomedical research. The webinar will provide an opportunity to discuss innovative omics data integration approaches that are revolutionising biomedical research and personalised therapies for neuromuscular diseases and arrhythmogenic...
🚀 We are excited to share that the first webinar dedicated to the IMPACT Project was held yesterday! During the webinar, Alessandra Rampazzo, professor at the Università degli Studi di Padova and coordinator of the Project, introduced the IMPACT Project, explaining its vision, goals, and potential in the research of new therapies. Next, Michele M....
The IMPACT Project is excited to invite you to a dedicated webinar, an opportunity to explore innovative approaches in the treatment of arrhythmogenic cardiomyopathy (ACM). During the webinar, we will explore the IMPACT Project and its partners, focusing on the importance of cardiomyopathies and the role of artificial intelligence (AI) in the discovery of new therapies, through the voices of...
On 26th-27th of September University of Studies of Padua hosted the First Year Consortium Meeting of the #IMPACT project (Cardiogenomics meets Artificial Intelligence: a step forward in arrhythmogenic cardiomyopathy diagnosis and treatment), funded by the European Union.
On 26th-27th of October University of Studies of Padua hosted the Kick-off Meeting of the newly started #IMPACT project (Cardiogenomics meets Artificial Intelligence: a step forward in arrhythmogenic cardiomyopathy diagnosis and treatment), funded by the European Union.
The IMPACT project has officially started! With 7 Partners from different EU countries 🇪🇺 , IMPACT will implement an Artificial Intelligence (AI)-based integration of clinical and -omics data from ACM patient registry utilizing unsupervised mixed-data clustering and phenomapping to identify phenotypic subgroups within the cohort of patients leading to the detection of therapeutically actionable targets...
Credits: Data Symposium
